Astera Labs downgraded to Equal Weight from Overweight at Barclays

Barclays analyst Tom O’Malley downgraded Astera Labs (ALAB) to Equal Weight from Overweight with an unchanged price target of $155. The company is undergoing a “major” product transition from the retiming portfolio to the switching products, the analyst tells investors in a research note. The firm says that beyond Trainium 3, it has not seen signs of Astera’s United Airlines adoption or momentum. Barclays also sees the world moving towards Ethernet.

Claim 30% Off TipRanks